Literature DB >> 10910366

The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome.

D H Streeten1, D Thomas, D S Bell.   

Abstract

BACKGROUND: Orthostatic hypotension during upright tilt is an important physical disorder in patients with chronic fatigue syndrome. We have tested its occurrence during prolonged standing, whether it is correctable, and whether reduced circulating erythrocyte volume is present.
METHODS: Fifteen patients were randomly selected from a large population of patients with chronic fatigue syndrome, studied, and observed for several years (by DSB). Blood pressure (BP) and heart rate (HR) measured with Dinamap every minute for 30 minutes supine and 60 minutes standing were compared with these findings in 15 healthy age- and gender-matched control subjects and later during lower body compression with military antishock trousers (MAST). Plasma catecholamines and circulating erythrocyte and plasma volumes were also measured by isotopic dilution methods.
RESULTS: Abnormal findings in the patients included excessive orthostatic reductions in systolic (P < 0.001) and diastolic BP (P < 0.001) and excessive orthostatic tachycardia (P < 0.01), together with presyncopal symptoms in 11 of the 15 patients and in none of the control subjects after standing for 60 min. Lower body compression with the MAST restored all orthostatic measurements to normal and overcame presyncopal symptoms within 10 min. Circulating erythrocyte but not plasma volumes were subnormal in the 12 women (P < 0.01) and plasma norepinephrine concentration rose excessively after standing for 10 min.
CONCLUSION: Delayed orthostatic hypotension and/or tachycardia caused by excessive gravitational venous pooling, which is correctable with external lower-body compression, together with subnormal circulating erythrocyte volume, are very frequent, although not invariably demonstrable, findings in moderate to severe chronic fatigue syndrome. When present, they may be involved in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910366     DOI: 10.1097/00000441-200007000-00001

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  36 in total

Review 1.  Postural tachycardia syndrome--current experience and concepts.

Authors:  Christopher J Mathias; David A Low; Valeria Iodice; Andrew P Owens; Mojca Kirbis; Rodney Grahame
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Blood pressure variability and closed-loop baroreflex assessment in adolescent chronic fatigue syndrome during supine rest and orthostatic stress.

Authors:  Vegard Bruun Wyller; Riccardo Barbieri; J Philip Saul
Journal:  Eur J Appl Physiol       Date:  2010-10-02       Impact factor: 3.078

Review 3.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

4.  Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort.

Authors:  D E J Jones; N Bhala; J Burt; J Goldblatt; M Prince; J L Newton
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

5.  Mortality in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.

Authors:  Stephanie L McManimen; Andrew R Devendorf; Abigail A Brown; Billie C Moore; James H Moore; Leonard A Jason
Journal:  Fatigue       Date:  2016-10-12

Review 6.  Confounders of vasovagal syncope: postural tachycardia syndrome.

Authors:  Victor C Nwazue; Satish R Raj
Journal:  Cardiol Clin       Date:  2013-02       Impact factor: 2.213

7.  Low iron storage in children with tilt positive neurally mediated syncope.

Authors:  Baris Guven; Taliha Oner; Vedide Tavli; Murat Muhtar Yilmazer; Savas Demirpence; Timur Mese
Journal:  World J Pediatr       Date:  2012-12-29       Impact factor: 2.764

8.  Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome.

Authors:  A R Light; L Bateman; D Jo; R W Hughen; T A Vanhaitsma; A T White; K C Light
Journal:  J Intern Med       Date:  2011-07-13       Impact factor: 8.989

9.  Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease.

Authors:  Julia L Newton; Jessie Pairman; Katharine Wilton; David E J Jones; Christopher Day
Journal:  Clin Auton Res       Date:  2009-12       Impact factor: 4.435

10.  Construction and validation of a fatigue impact scale for daily administration (D-FIS).

Authors:  John D Fisk; Susan E Doble
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.